Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.

Poleszak E, Stasiuk W, Szopa A, Wyska E, Serefko A, Oniszczuk A, Wośko S, Świąder K, Wlaź P.

Metab Brain Dis. 2016 Aug;31(4):803-14. doi: 10.1007/s11011-016-9810-5. Epub 2016 Feb 29.

2.

New targets for rapid antidepressant action.

Machado-Vieira R, Henter ID, Zarate CA Jr.

Prog Neurobiol. 2017 May;152:21-37. doi: 10.1016/j.pneurobio.2015.12.001. Epub 2015 Dec 23. Review.

PMID:
26724279
3.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

4.

Mechanisms underlying the antidepressant response and treatment resistance.

Levinstein MR, Samuels BA.

Front Behav Neurosci. 2014 Jun 27;8:208. doi: 10.3389/fnbeh.2014.00208. eCollection 2014. Review.

5.

Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.

Holubova K, Nekovarova T, Pistovcakova J, Sulcova A, Stuchlík A, Vales K.

Front Behav Neurosci. 2014 Apr 16;8:130. doi: 10.3389/fnbeh.2014.00130. eCollection 2014.

6.

Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.

Pozzi L, Pollak Dorocic I, Wang X, Carlén M, Meletis K.

PLoS One. 2014 Jan 16;9(1):e83879. doi: 10.1371/journal.pone.0083879. eCollection 2014. Erratum in: PLoS One. 2014;9(2):e91486. Dorocic, Iskra Pollak [corrected to Pollak Dorocic, Iskra].

7.

Reduced levels of NR1 and NR2A with depression-like behavior in different brain regions in prenatally stressed juvenile offspring.

Sun H, Guan L, Zhu Z, Li H.

PLoS One. 2013 Nov 20;8(11):e81775. doi: 10.1371/journal.pone.0081775. eCollection 2013.

8.

NMDA Receptor Antagonists for Treatment of Depression.

Ates-Alagoz Z, Adejare A.

Pharmaceuticals (Basel). 2013 Apr 3;6(4):480-99. doi: 10.3390/ph6040480.

9.

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Krystal JH, Sanacora G, Duman RS.

Biol Psychiatry. 2013 Jun 15;73(12):1133-41. doi: 10.1016/j.biopsych.2013.03.026. Review.

10.

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Manji HK, Zarate CA Jr, Drevets WC.

Biol Psychiatry. 2013 Jun 15;73(12):1213-21. doi: 10.1016/j.biopsych.2013.02.008. Epub 2013 Mar 27.

11.

Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Mathews DC, Henter ID, Zarate CA.

Drugs. 2012 Jul 9;72(10):1313-33. doi: 10.2165/11633130-000000000-00000. Review.

12.

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Siddiqui N, Andalip, Bawa S, Ali R, Afzal O, Akhtar MJ, Azad B, Kumar R.

J Pharm Bioallied Sci. 2011 Apr;3(2):194-212. doi: 10.4103/0975-7406.80765.

13.

A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice.

Poleszak E, Wlaź P, Szewczyk B, Wlaź A, Kasperek R, Wróbel A, Nowak G.

J Neural Transm (Vienna). 2011 Nov;118(11):1535-46. doi: 10.1007/s00702-011-0630-9. Epub 2011 Apr 2.

14.

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr.

Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.

15.

Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Aboukhatwa M, Dosanjh L, Luo Y.

Mol Neurodegener. 2010 Mar 12;5:10. doi: 10.1186/1750-1326-5-10.

16.

Implication of the polyamine system in mental disorders.

Fiori LM, Turecki G.

J Psychiatry Neurosci. 2008 Mar;33(2):102-10. Review.

17.

Advances in the treatment of anxiety: targeting glutamate.

Simon AB, Gorman JM.

NeuroRx. 2006 Jan;3(1):57-68. Review.

18.

Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression.

Karolewicz B, Stockmeier CA, Ordway GA.

Neuropsychopharmacology. 2005 Aug;30(8):1557-67.

19.

Low nNOS protein in the locus coeruleus in major depression.

Karolewicz B, Szebeni K, Stockmeier CA, Konick L, Overholser JC, Jurjus G, Roth BL, Ordway GA.

J Neurochem. 2004 Dec;91(5):1057-66.

Supplemental Content

Support Center